At first sight, there is nothing in common between Berkshire Hathaway's ( BRK.A ) ( BRK.B ) See’s Candies and Mettler-Toledo (NYSE: MTD ). Except perhaps that See’s may use a few of the other'sStriving to compound knowledge. Long-time fan of Warren and Charlie. Always invert. "To finish first, you must first finish". Investing own and family funds for +20 years. Senior finance roles at public and private corporations for most of that time.Analyst’s Disclosure: I/we have a beneficial long position in the sha ...

应用工程师 石化行业-成都- 2 5 - 3 5 k . 1 3薪 安东帕(上海)商贸有限公司 销售工程师（微波光学） 南京-面议 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 仪粉e r们，今天2 0 2 4年杰出雇主专辑： 加入 内推求职群 ，小谱君和仪小职会在群里为大家 内推简历 哦！ 先Po一波 杰出雇主职位 （奖项在职位后）： 安捷伦科技(中国)有限公司 北京莱伯泰科仪器股份有限公司 销售工程 师 合肥- 8 k - 1 2 k · 1 3薪 北京东西分析仪器有限公司 销售工程师 北京- 6 k - 8 k · 1 2薪 湖南力辰仪器科技有限公司 外贸负责人 青岛- 1 2 k - 2 0 k · 1 3薪 梅特勒托利多 软件测试实习生 上海-面议 牛津仪器科技（上海）有限公司 Na n o -I n d e n t e r BD 纳米压痕仪业务拓展经理 上海-面议 青岛盛瀚色谱技术有限公司 昆明-面议 天美仪拓实验室设备（上海） 有限公司 实验室产品销售 产品经理（离子色谱耗材） 青岛- 8 k - 1 5 k · 1 ...

Summary of Mettler-Toledo International (MTD) Conference Call Company Overview - **Company**: Mettler-Toledo International (MTD) - **Date of Conference**: May 14, 2025 - **Speaker**: Sean Vidalia, Chief Financial Officer Key Points Financial Performance - **1Q Results**: MTD reported a 3% growth in underlying business, excluding shipping delays [3][4] - **Lab Business Growth**: Mid single-digit growth, with process analytics business growing just under 10% [3][4] - **Product Inspection**: Grew by 8%, indicating strong execution and new product introductions [4][5] - **Liquid Handling Business**: Experienced slight decline, affected by small biotech and academia sectors [4] Fiscal Year 2025 Guidance - **Tariff Impact**: Adjusted top-line guidance due to trade war uncertainties, with a 2% reduction in EPS guidance [6][8] - **Tariff Costs**: Estimated gross tariff headwind of $115 million annually, translating to a 7% headwind to EPS [11][12] - **China Tariff Changes**: Anticipated benefits from temporary de-escalation of tariffs, with a potential 3.5% EPS benefit [11][16] Market Dynamics - **China Market Outlook**: Initial expectations of low single-digit growth revised to slight decline; however, potential for future growth remains [28][32] - **Emerging Markets**: Growth in Southeast Asia, India, and Eastern Europe, now representing 18% of MTD's business, surpassing China [33][34] - **Academic and Government Sector**: Low single-digit percentage of global business; softness noted in both consumables and instruments [37][39] Biopharma and Process Analytics - **Bioprocessing**: Strong performance in process analytics, particularly with single-use technologies [42][45] - **Life Sciences Exposure**: Comprises about 40% of MTD's business, with a focus on production and QA/QC labs [46] Industrial Sector - **Core Industrial Business**: Represents 25% of MTD's business; guidance for flattish growth due to economic softness [49][50] - **Chemicals Sector**: Noted as softer relative to other end markets, indicating cyclicality [51] Reshoring and Supply Chain - **Reshoring Trends**: Companies are adopting "China plus one" strategies, diversifying supply chains to include emerging markets [35][36] - **Automation Demand**: Increased focus on automated solutions as companies seek productivity amidst rising costs [58][59] Margin Expansion Opportunities - **P&L Levers**: Continuous improvement culture, innovation, and pricing strategies are key to margin expansion [62][64] - **Cash Flow**: Strong cash flow conversion at approximately 100% [65][66] Underappreciated Aspects - **Diversity of Solutions**: MTD's ability to provide solutions across the entire value chain is a significant strength, especially in the context of reshoring [66] Additional Insights - **Market Uncertainty**: Ongoing uncertainties in the market, particularly regarding China, will be closely monitored for future guidance updates [27][29] - **Long-term Growth**: Despite current challenges, MTD remains optimistic about future growth opportunities in various sectors [32][33]

Mettler-Toledo International (MTD) shares gained 4.11% to close at $1,100.01 on May 2 following an impressive first-quarter 2025 results, driven by positive outlook and solid growth in laboratory business, driven by recent innovations like the new line of laboratory balances, titrators and thermal analysis instruments.MTD reported first-quarter 2025 adjusted earnings of $8.19 per share, which beat the Zacks Consensus Estimate by 3.67%. The bottom line declined 7.9% on a year-over-year basis. Net sales of $8 ...

Financial Performance - Net sales for the three months ended March 31, 2025, were $883.7 million, a decrease of 5% compared to $925.9 million in the same period of 2024[90] - Net earnings for the three months ended March 31, 2025, were $163.6 million, down from $177.5 million in the same period of 2024, reflecting a decrease in earnings before taxes[90] - Total net sales decreased 19% in U.S. dollars and 17% in local currency for the three months ended March 31, 2025 compared to the same period in 2024[114] - Net sales to external customers decreased 13% in U.S. dollars and 11% in local currency for the three months ended March 31, 2025 compared to the same period in 2024[114] - Total net sales decreased 10% in U.S. dollars and 8% in local currencies during the three months ended March 31, 2025 compared to the same period in 2024[117] Profitability and Expenses - Gross profit margin increased to 59.5% for the three months ended March 31, 2025, compared to 59.2% in the corresponding period in 2024, driven by favorable price realization[103] - Research and development expenses were $46.3 million, representing 5.2% of net sales, compared to 5.0% in the same period of 2024[106] - Selling, general and administrative expenses increased to $242.8 million, or 27.5% of net sales, up from 25.3% in the prior year[107] - Segment profit for U.S. Operations decreased by $9.3 million to $84.3 million for the three months ended March 31, 2025, impacted by lower sales volume and higher expenses[113] - Segment profit decreased by $7.3 million for the three-month period ended March 31, 2025 compared to the same period in 2024[118] Regional Sales Performance - Net sales in the Americas decreased by 2%, while Europe saw a 9% decline, and Asia/Rest of World experienced a 4% decrease in U.S. dollars for the three months ended March 31, 2025[96] - In Western European Operations, net sales to external customers decreased by 11% to $190.4 million for the three months ended March 31, 2025 compared to $214.8 million in 2024[116] Cash Flow and Capital Management - Cash provided by operating activities totaled $194.4 million during the three months ended March 31, 2025, compared to $190.0 million in the same period in 2024[129] - Capital expenditures totaled $17.3 million for the three months ended March 31, 2025 compared to $17.4 million in the same period in 2024[130] - As of March 31, 2025, approximately $679.8 million of additional borrowings was available under the Credit Agreement[132] - The company has $1.5 billion of remaining availability for its share repurchase program as of March 31, 2025[137] - The company has repurchased 32.5 million common shares at an average price of $307.74 since the program's inception in 2004 through March 31, 2025[138] - In Q1 2025, the company spent $218.7 million to repurchase 170,957 shares at an average price of $1,279.54, compared to $212.5 million for 173,700 shares at $1,223.35 in Q1 2024[138] Tax and Currency Impact - The company incurred $2.0 million and $2.1 million in excise tax during Q1 2025 and 2024, respectively, related to the Inflation Reduction Act[138] - A 1% strengthening of the Swiss franc against the euro is estimated to reduce earnings before tax by approximately $2.4 million to $2.7 million annually[139] - A 1% weakening of the Chinese renminbi against the U.S. dollar is estimated to reduce earnings before tax by approximately $2.2 million to $2.5 million annually[140] - A 5% weakening of the U.S. dollar against the currencies in which the company's debt is denominated would result in an increase of approximately $47.6 million in the reported U.S. dollar value of the debt[141] Risks and Uncertainties - The company expects gross margin to be negatively impacted by the recent escalation in global trade disputes and tariffs throughout 2025[105] - The company cautions that actual results may differ materially from forward-looking statements due to various risks and uncertainties, including global trade disputes and inflation[142] - There was no material change in market risk information as of March 31, 2025, compared to the previous annual report[144]

Mettler-Toledo International (MTD) Q1 2025 Earnings Call May 02, 2025 08:30 AM ET Speaker0 Good morning, ladies and gentlemen, and thank you for standing by. My name is Kelvin, and I will be your conference operator today. At this time, I would like to welcome everyone to the Mettler Toledo First Quarter twenty twenty five Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. Thank you. I would now like to ...

Financial Data and Key Metrics Changes - Sales in the quarter were $884 million, representing a decrease of 3% in local currency, while reported sales declined by 5% in U.S. dollars [8][9] - Adjusted operating profit amounted to $237 million, down 11% from the prior year, with an adjusted operating margin of 26.8%, a decrease of 20 basis points [12][14] - Adjusted EPS for the quarter was $8.19, an 8% decrease over the prior year, while reported EPS was $7.81 compared to $8.24 in the prior year [13][14] Business Line Data and Key Metrics Changes - Laboratory sales decreased by 3%, while Industrial sales declined by 1%, with Core Industrial down 6% and Product Inspection up 8% [10] - Service sales increased by 6% in local currency during the first quarter [11] - Excluding the impact of shipping delay recoveries, Laboratory sales grew by 5%, Industrial grew by 2%, and Food Retail declined by 5% [11] Market Data and Key Metrics Changes - Local currency sales declined by 1% in The Americas, 7% in Europe, and 2% in Asia Rest of the World [9] - Local currency sales in China were flat during the quarter, with a 3% growth excluding the impact of shipping delay recoveries [10] - Market conditions in China remain soft, with increased economic uncertainty [27] Company Strategy and Development Direction - The company is implementing various actions to offset the impact of higher tariffs, including supply chain optimization, cost savings, price increases, and surcharges [17][31] - The company remains focused on growth, innovation, and operational excellence, leveraging its diverse product portfolio and geographic presence [28][32] - The company is well-positioned to benefit from onshoring investments and has a strong direct sales force to communicate its value proposition [30][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the dynamic environment despite ongoing global trade disputes and tariffs, which have increased uncertainty in customer demand [7][27] - The outlook assumes market conditions will be slower than previously expected, particularly in China, with volume growth in the second half of the year expected to be similar to the first half [18][20] - Management highlighted the importance of their strong culture of teamwork and collaboration in successfully navigating uncertainty [27][32] Other Important Information - The company estimates incremental global tariff costs at approximately $115 million on an annualized basis [16][20] - Free cash flow for the quarter was $180 million, a 1% increase on a per-share basis [14][22] - The company expects total amortization to be approximately $72 million for the year, with interest expense forecasted at $72 million [21] Q&A Session Summary Question: Update on revenue growth forecast in China - For 2025, the company expects China to be down slightly, with lab business up low single digits and industrial business down low single digits [35][36] Question: Potential opportunity from manufacturing onshoring initiatives - The company is in discussions with customers about the benefits of its portfolio for manufacturing control systems, but the impact from reshoring is not yet significant [39][40] Question: Breakdown of tariff impact and mitigation efforts - The company estimates $50 million in tariff exposure from China and $250 million from imports to the U.S., with pricing expected to increase by about 3% [46][47][49] Question: Insights on the industrial market and customer behavior - Management noted some delays in larger projects in China, but overall, they remain confident in their automation solutions for the industrial market [53][55] Question: Services growth outlook - The company forecasts mid to high single-digit growth in services for 2025, supported by investments in marketing and sales resources [97][99] Question: Impact of tariffs on EPS guidance - The company expects a gross headwind of about 7% to EPS from tariffs, with mitigation actions expected to offset approximately 75% of that impact [88][101]

Core Viewpoint - Mettler-Toledo reported quarterly earnings of $8.19 per share, exceeding the Zacks Consensus Estimate of $7.90, but down from $8.89 per share a year ago, indicating a 7.9% year-over-year decline in earnings [1][2] Financial Performance - The company achieved revenues of $883.74 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1%, but down from $925.95 million in the same quarter last year, reflecting a year-over-year revenue decline of 4.6% [2] - Mettler-Toledo has consistently surpassed consensus EPS estimates over the last four quarters, achieving an earnings surprise of 3.67% in the latest report [1][2] Stock Performance - Mettler-Toledo shares have declined approximately 12.5% since the beginning of the year, compared to a 5.3% decline in the S&P 500 [3] - The current Zacks Rank for Mettler-Toledo is 3 (Hold), indicating that the stock is expected to perform in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $10.22, with expected revenues of $957.72 million, while the estimate for the current fiscal year is $42.51 on revenues of $3.91 billion [7] - The trend of estimate revisions for Mettler-Toledo is currently mixed, which may change following the latest earnings report [6] Industry Context - The Medical - Instruments industry, to which Mettler-Toledo belongs, is currently ranked in the top 23% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Sales Performance - First quarter 2025 total reported sales declined 5% to $883.7 million compared to the prior year, with local currency sales decreasing 3%[3][5] - The Americas reported a 2% decline in sales, Europe saw a 9% decrease, and Asia/Rest of World experienced a 4% decline compared to the prior year[3][5] - For the three months ended March 31, 2025, U.S. Dollar Sales Growth was down by 5%, with declines of 2% in the Americas, 9% in Europe, and 4% in Asia/Rest of World[23] - Local Currency Sales Growth for the same period showed a decrease of 3%, with a decline of 1% in the Americas, 7% in Europe, and 2% in Asia/Rest of World[23] - The company estimates that net sales growth was reduced by approximately 6% due to the recovery of delayed shipments from Q1 2024; excluding this impact, local currency net sales increased by 3% overall[23] Earnings and Profitability - Adjusted EPS for the quarter was $8.19, an 8% decrease from the prior-year amount of $8.89[4][8] - Adjusted Operating Profit amounted to $236.7 million, down 11% from $267.3 million in the same period last year[5][18] - Net earnings for the quarter were $163.6 million, down from $177.5 million in the prior-year period[21] - Diluted EPS as reported for Q1 2025 was $7.81, a decrease of 5% compared to $8.24 in Q1 2024[25] - Adjusted diluted EPS for Q1 2025 was $8.19, reflecting an 8% decline from $8.89 in Q1 2024[25] - The impact of purchased intangible amortization on EPS was $0.23 for Q1 2025, compared to $0.24 in Q1 2024[25] - Restructuring charges impacted EPS by $0.15 in Q1 2025, down from $0.36 in Q1 2024[26] - The company incurred restructuring charges of $3.8 million in Q1 2025, compared to $9.7 million in Q1 2024[26] Future Outlook - Management anticipates local currency sales for Q2 2025 to increase approximately 0% to 1%, with Adjusted EPS forecasted to be between $9.45 and $9.70, reflecting a growth rate of down 2% to up 1%[7][9] - For the full year 2025, local currency sales are expected to increase approximately 1% to 2%, with Adjusted EPS projected in the range of $41.25 to $42.00[8][9] Tariff Impact - The company estimates gross incremental global tariff costs of approximately $115 million on an annualized basis, impacting future earnings[11] - The company is implementing mitigating actions to offset tariff costs, which are expected to fully offset these costs next year[11] Cash Position - Cash and cash equivalents increased to $64.3 million from $59.4 million at the end of the previous year[20]

Summary Comments Earnings Call Webcast May 2, 2025 Mettler-Toledo International Inc. Q1 2025 Financial Results Safe Harbor Statement 2 Statements in this presentation which are not historical facts constitute "forward looking statements" within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. These statements involve known and unknown risks, uncertainties and other factors that may cause our or our businesses, actual results, levels o ...